Jubilant Pharmova Limited (JUBLPHARMA.BO)
INR 881.1
(-0.37%)
INR 881.1
(-0.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 31.67 Billion INR | -4.71% |
| 2022 | 33.23 Billion INR | 24.18% |
| 2021 | 26.76 Billion INR | -3.01% |
| 2020 | 27.59 Billion INR | -28.8% |
| 2019 | 38.75 Billion INR | -8.65% |
| 2018 | 42.42 Billion INR | 39.21% |
| 2017 | 30.47 Billion INR | -13.04% |
| 2016 | 35.05 Billion INR | 16.32% |
| 2015 | 30.13 Billion INR | -17.71% |
| 2014 | 36.61 Billion INR | 113.27% |
| 2013 | 17.16 Billion INR | -30.46% |
| 2012 | 24.68 Billion INR | -13.07% |
| 2011 | 28.39 Billion INR | 0.12% |
| 2010 | 28.36 Billion INR | -10.6% |
| 2009 | 31.72 Billion INR | -19.51% |
| 2008 | 39.41 Billion INR | 86.95% |
| 2007 | 21.08 Billion INR | 27.58% |
| 2006 | 16.52 Billion INR | 128.88% |
| 2005 | 7.22 Billion INR | 94.16% |
| 2004 | 3.71 Billion INR | -11.67% |
| 2003 | 4.21 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 25.41 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 31.67 Billion INR | 0.0% |
| 2023 Q2 | 33.66 Billion INR | 0.0% |
| 2023 FY | 31.67 Billion INR | -4.71% |
| 2022 Q2 | 32.19 Billion INR | 0.0% |
| 2022 Q4 | 33.23 Billion INR | 0.0% |
| 2022 FY | 33.23 Billion INR | 24.18% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 28.12 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 26.76 Billion INR | 0.0% |
| 2021 FY | 26.76 Billion INR | -3.01% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 27.59 Billion INR | -28.8% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 27.59 Billion INR | 0.0% |
| 2020 Q2 | 36.19 Billion INR | 0.0% |
| 2019 Q2 | 41.82 Billion INR | 0.0% |
| 2019 FY | 38.75 Billion INR | -8.65% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 38.75 Billion INR | 0.0% |
| 2018 FY | 42.42 Billion INR | 39.21% |
| 2018 Q4 | 42.42 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 35.28 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 FY | 30.47 Billion INR | -13.04% |
| 2017 Q2 | 31.84 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 30.47 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 35.05 Billion INR | 16.32% |
| 2016 Q2 | 29.59 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 35.05 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 30.13 Billion INR | -17.71% |
| 2015 Q4 | 30.13 Billion INR | 0.0% |
| 2015 Q2 | 31.05 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q4 | 36.61 Billion INR | 0.0% |
| 2014 FY | 36.61 Billion INR | 113.27% |
| 2014 Q2 | 30.36 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q4 | 17.16 Billion INR | 0.0% |
| 2013 FY | 17.16 Billion INR | -30.46% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 18.31 Billion INR | 0.0% |
| 2012 Q4 | 24.68 Billion INR | 0.0% |
| 2012 FY | 24.68 Billion INR | -13.07% |
| 2011 FY | 28.39 Billion INR | 0.12% |
| 2011 Q4 | 28.39 Billion INR | 0.0% |
| 2010 FY | 28.36 Billion INR | -10.6% |
| 2009 FY | 31.72 Billion INR | -19.51% |
| 2008 FY | 39.41 Billion INR | 86.95% |
| 2007 FY | 21.08 Billion INR | 27.58% |
| 2006 FY | 16.52 Billion INR | 128.88% |
| 2005 FY | 7.22 Billion INR | 94.16% |
| 2004 FY | 3.71 Billion INR | -11.67% |
| 2003 FY | 4.21 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -4936.737% |
| Aurobindo Pharma Limited | 21.34 Billion INR | -48.349% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -21355.863% |
| Granules India Limited | 689.71 Million INR | -4491.93% |
| Indoco Remedies Limited | 3.51 Billion INR | -800.435% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -13365.561% |
| Alkem Laboratories Limited | 400 Million INR | -7817.75% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -888287.097% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -113677.123% |
| Bajaj HealthCare Limited | 650.34 Million INR | -4769.877% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -8798.298% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -428.731% |
| Eris Lifesciences Limited | 6.54 Billion INR | -383.891% |
| FDC Limited | 2.46 Million INR | -1284206.569% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -1987.863% |
| Gufic Biosciences Limited | 1.53 Billion INR | -1957.051% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -28272.422% |
| Ipca Laboratories Limited | 5.8 Billion INR | -445.666% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -41809.488% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -1625.94% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | -268.101% |
| Lupin Limited | 1.55 Billion INR | -1939.606% |
| Mankind Pharma Limited | 248.67 Million INR | -12635.798% |
| Medicamen Biotech Limited | 12.55 Million INR | -252158.065% |
| Medico Remedies Limited | 8.67 Million INR | -365109.871% |
| Megasoft Limited | 1.35 Billion INR | -2233.78% |
| NATCO Pharma Limited | 53 Million INR | -59656.604% |
| Piramal Pharma Limited | 24.83 Billion INR | -27.513% |
| RPG Life Sciences Limited | -30.3 Million INR | 104624.752% |
| Sigachi Industries Limited | 265.79 Million INR | -11815.44% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -238027.82% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -14814.107% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 2598213.208% |
| Unichem Laboratories Limited | 382.22 Million INR | -8186.044% |
| Wanbury Limited | 820 Million INR | -3762.317% |
| Windlas Biotech Limited | 20.18 Million INR | -156842.517% |
| ZIM Laboratories Limited | 356 Million INR | -8796.198% |
| Zydus Lifesciences Limited | 251 Million INR | -12517.928% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -29610.131% |
| Divi's Laboratories Limited | 20 Million INR | -158255.0% |
| Hester Biosciences Limited | 1.81 Billion INR | -1642.338% |
| Procter & Gamble Health Limited | 68.8 Million INR | -45933.43% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -226639.691% |
| Bal Pharma Limited | 363.82 Million INR | -8605.033% |
| Strides Pharma Science Limited | 6.71 Billion INR | -371.646% |
| Venus Remedies Limited | 386.8 Million INR | -8087.952% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -7917650.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -2157.237% |
| Shilpa Medicare Limited | 5.6 Billion INR | -465.392% |
| Aarti Drugs Limited | 2.75 Billion INR | -1050.292% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | -213.728% |
| Valiant Laboratories Limited | 746.63 Million INR | -4141.86% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -13297.208% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -2892.63% |
| Themis Medicare Limited | 267.74 Million INR | -11729.013% |
| Hikal Limited | 4.22 Billion INR | -648.989% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | -97.45% |
| Sequent Scientific Limited | 1.42 Billion INR | -2119.116% |
| Novartis India Limited | 50.7 Million INR | -62367.456% |
| Wockhardt Limited | 8.91 Billion INR | -255.455% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -6950.44% |
| Morepen Laboratories Limited | 33.64 Million INR | -94046.849% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -23616.312% |